ASSESSING THE TREATMENT RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS AFTER NEW COMBINATION TREATMENT

EHA Library, Basma Atef, 421370

CARDINAL: A PHASE I, MULTICENTER, OPEN-LABEL, DOSE-ESCALATION AND DOSE-OPTIMIZATION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF TERN-701 IN CHRONIC MYELOID LEUKEMIA

EHA Library, Elias Jabbour, 421371

PROGNOSTIC RESTRATIFICATION OF A COHORT OF 72 PATIENTS DIAGNOSED WITH MYELODYSPLASTIC SYNDROMES (MDS) USING THE MOLECULAR INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS-M).

EHA Library, Blanca Vegas, 421372

PANOBINOSTAT AND PIM-2 INHIBITORS PROMOTE THE APOPTOSIS OF MDS/AML MALIGNANT CELLS BY INHIBITING THE NF-ΚB PATHWAY

EHA Library, Zhaoyun Liu, 421373

THE POTENTIAL ROLE OF UBE2O IN THE TREATMENT OF INEFFECTIVE ERYTHROPOIESIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Beatrice Maffeo, 421374

TARGETING XPO1 AND PRL-3 INDUCED MITOCHONDRIAL DAMAGE AND APOPTOSIS IN MDS THERAPY

EHA Library, Zhaoyun Liu, 421375

THE EFFECTIVENESS OF COMBINING GLUTAMINASE INHIBITORS WITH THE DIABETIC MEDICATION METFORMIN IN TREATING MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA

EHA Library, Seiichi Okabe, 421376

EFFECT OF EPIGENETIC CHANGES IN PROGNOSIS OF YOUNG INDIAN PATIENTS WITH MYELODYSPLASTIC SYNDROMES : INDIAN STUDY

EHA Library, Rekha Chaubey, 421377

EPIGENETIC LANDSCAPE OF MDS EVOLUTION WITH 1Q JUMPING TRANSLOCATIONS AFTER 5’-AZACYTIDINE

EHA Library, Anair Graciela Lema Fernandez, 421378

FTH1 REPRESSES FERRITINOPHAGY-MEDIATED FERROPTOSIS IN THE ANEMIC PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES

EHA Library, Liyan Yang, 421379

RESTORATION OF WNT INHIBITOR DICKKOPF-1 LEVELS NORMALIZES BONE MINERALIZATION BUT NOT ERYTHROPOIESIS IN MYELODYSPLASTIC MICE

EHA Library, Heike Weidner, 421380

BONE MARROW MESENCHYMAL STROMAL CELLS MODULATION IN MYELODYSPLASTIC SYNDROMES.

EHA Library, Matilde Boada, 421381

PROGNOSTIC IMPACT OF DONOR MITOCHONDRIAL GENOMIC VARIANTS IN MYELODYSPLASTIC NEOPLASMS AFTER STEM-CELL TRANSPLANTATION

EHA Library, Jing Dong, 421382

INCREASING ANTI-APOPTOTIC AND DECREASING PROLIFERATIVE ACTIVITY IN THE CD34-POSITIVE BLAST CELL POPULATION OF MDS AND AML AS COMPARED TO NON-MALIGNANT BONE MARROW

EHA Library, Math Leers, 421383

THE MESENCHYMAL STROMAL CELLS: A HUB FOR NATURAL KILLER CELL IMMUNE DYSREGULATION  IN MDS CONTEXT

EHA Library, Valeria Bisio, 421384

DEVELOPMENT OF APTAMERS AS THERAPY FOR CONGENITAL NEUTROPENIA DISEASES

EHA Library, Francisca Alcaraz-Pérez, 421385

VARIABILITY IN INTERPRETATION OF ARRAY RESULTS IMPACTING ON CORRECT PROGNOSTICATION OF MANY HAEMATOLOGICAL MALIGNANCIES – THROUGH AN EQA LENS

EHA Library, Fiona Oswald, 421386

GERMLINE DDX41 MUTATION IN SIBLING DONOR AND TRANSPLANT RECIPIENT, WITH IDENTICAL SECOND HIT DDX41 APPEARING YEARS LATER CAUSING DONOR DERIVED MYELODYSPLASTIC SYNDROME

EHA Library, Liselotte Vesterlund, 421387

THE MAXILUS STUDY: A TRIAL IN PROGRESS FOR LUSPATERCEPT AT MAXIMUM APPROVED DOSE IN PATIENTS WITH TRANSFUSION-DEPENDENT LOWER-RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Matteo Giovanni Della Porta, 421388

CLINICAL IMPACT OF ASXL1 MUTATIONS IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC NEOPLASMS (HR-MDS) TREATED WITH HYPOMETHYLATING AGENTS: MULTICENTER RETROSPECTIVE ANALYSIS FROM THE VALIDATE DATABASE

EHA Library, Aram Bidikian, 421389

PLATELET FUNCTION PARAMETERS IN RELATION TO SOMATIC MYELOID MUTATIONS AND OUTCOME IN CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Ebba Westerberg, 421390

THE EFFICACY OF LUSPATERCEPT IN TREATING REFRACTORY ANEMIA MIGHT NOT BE AFFECTED BY IPSS-R OR IPSS-M RISK

EHA Library, Guangsheng He, 421391

CYTOGENETIC ANNOTATION AUTOMATION IN MYELODYSPLASTIC SYNDROME RESEARCH DATABASES

EHA Library, Samuel Urrutia, 421392

TRIAL IN PROGRESS: PHASE II STUDY OF THE NLRP3 INFLAMMASOME & MYDDOSOME INHIBITOR HT-6184 IN PATIENTS WITH LOW OR INTERMEDIATE-RISK MYELODYSPLASTIC SYNDROME (MDS)

EHA Library, David J. Bearss, 421393

SOME RISK FACTORS FOR THE PROGRESSION OF MYELODYSPLASTIC SYNDROME TO ACUTE MYELOID LEUKEMIA

EHA Library, Halyna Starodub, 421394

MANAGEMENT OF PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) IN A LARGE US COMMUNITY ONCOLOGY PRACTICE: A FOCUS ON PATIENT OUTCOMES POST ERYTHROPOIETIN STIMULATING AGENT (ESA) TREATMENT

EHA Library, Gustavo Fonseca, 421395

REAL-WORLD CHARACTERISTICS AND TREATMENT PATTERNS AMONG PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES IN JAPAN

EHA Library, Takahiro Suzuki, 421396

GERMLINE UBA1 VARIANT WITH SOMATIC AMPLIFICATION IN A WOMAN WITH REFRACTORY INFLAMMATORY DISEASES AND MYELODYSPLASTIC SYNDROME

EHA Library, Maria Creignou, 421397

REAL-WORLD OUTCOMES OF HYPOMETHYLATING AGENTS FOR HIGHER-RISK MYELODYSPLASTIC SYNDROMES: REPORT FROM THE NATIONWIDE MULTI-CENTER THAI MDS STUDY GROUP

EHA Library, Theerin Lanamtieng, 421398

SALVAGE VENETOCLAX+AZACITIDINE THERAPY FOR SECONDARY AML IN AZACITIDINE FAILED PATIENTS. SINGLE CENTER EXPERIENCE.

EHA Library, Lubomir Minarik, 421399

SLEEP DISTURBANCES IN PATIENTS WITH MYELODYSPLASTIC NEOPLASIAS

EHA Library, Ekaterina Balaian, 421400

MYELOID NEOPLASMS WITH GERMLINE PREDISPOSITION - DDX41 MUTATION

EHA Library, Mafalda Urbano, 421401

REAL WORLD EFFICACY OF LUSPATERCEPT IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES/NEOPLASMS (MDS); A SINGLE CENTER STUDY IN A HEAVILY PRETREATED COHORT

EHA Library, Yazan Madanat, 421402

REAL WORLD OUTCOMES OF DECITABINE/CEDAZURIDINE AND AZACITIDINE FOR TREATMENT OF MDS/CMML: A SINGLE INSTITUTION EXPERIENCE

EHA Library, Brittany Margaret-Anne salter, 421403

THROMBOCYTOPENIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES: A SINGLE CENTER ANALYSIS.

EHA Library, Nicole Galli, 421404

MANAGEMENT OF ANEMIA IN LOW-RISK MYELODYSPLASTIC SYNDROME PATIENTS IN LOW-RESOURCE SETTINGS: CONSIDERATIONS FOR IMMUNOSUPPRESSION OR ANDROGENS

EHA Library, Sebastian Burgos, 421405

DOES VENETOCLAX IMPROVE OUTCOMES IN HIGH-RISK MYELODYSPLASTIC SYNDROME? A RETROSPECTIVE MULTICENTER STUDY COMPARING AZACITIDINE-VENETOCLAX VS. AZACITIDINE MONOTHERAPY IN MEXICO

EHA Library, Lyam Carlo Chacon-Rangel, 421406

CLINICAL AND BIOLOGICAL INSIGHTS OF THERAPY-RELATED MYELOID NEOPLASMS FROM A SINGLE-CENTER

EHA Library, Sara García Ávila, 421407

A REAL-WORLD COMPARATIVE ANALYSIS OF FRONTLINE IDH1 MUTATED HIGHER-RISK MYELODYSPLASTIC SYNDROME TREATMENT RESPONSE: EVOLUTION FROM IWG 2006 TO IWG 2023 CRITERIA

EHA Library, Rihab Gamaoun, 421408

LUSPATERCEPT IN MDS WITH RING SIDEROBLASTS: A REAL-LIFE EXPERIENCE

EHA Library, Mara Memoli, 421409

THE CLINICAL OUTCOMES OF HAPLOIDENTICAL STEM CELL TRANSPLANTATION (HAPLO-HSCT) FOR PATIENTS WITH THERAPY-RELATED MYELODYSPLASTIC SYNDROME: COMPARABLE TO DE NOVO MYELODYSPLASTIC SYNDROME

EHA Library, Feifei Tang, 421410

IMPAIRMENT OF T CELL SUBSETS AND DEGRANULATION OF CYTOTOXIC T CELLS IN ACQUIRED APLASTIC ANEMIA

EHA Library, Vandana Sharma, 421411

SOMATIC MUTATIONS ANALYSIS OF CHEMOTHERAPY-INDUCED APLASTIC ANEMIA

EHA Library, Yueyang Zhang, 421412

PLASMODIUM FALCIPARUM INDUCED ACQUIRED APLASTIC ANEMIA INDUCED BY PLASMODIUM FALCIPARUM SUCCESSFULLY MANAGED BY ANTIMALARIALS AND HORSE ANTITHYMOCYTE GLOBULIN.

EHA Library, Rohit Kapoor, 421413

PATIENTS WITH SEVERE APLASTIC ANEMIA TREATED BY INTENSIVE IMMUNOSUPPRESSIVE THERAPY COMBINED WITH ELTROMBOPAG: MILD AGGRAVATION OF HEPATIC INJURY

EHA Library, Guangsheng He, 421414

RESPONSE AND OUTCOME OF PATIENTS WITH APLASTIC ANEMIA ARISING FROM ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENIA

EHA Library, Yannic Schumacher, 421415

BONE MARROW NECROSIS IN TWO PATIENTS

EHA Library, Mahmoud Ayesh (Haj Yousef), 421416

CLINICAL OUTCOME OF ACQUIRED APLASTIC ANEMIA : EXPERIENCE FROM A DEVELOPPING COUNTRY

EHA Library, Faten kallel, 421417

ACQUIRED APLASTIC ANAEMIA: CLINICO-HAEMATOLOGICAL FEATURES, MANAGEMENT AND OUTCOMES AT A CENTRAL SOUTH AFRICAN CENTRE

EHA Library, Debi Moagi, 421418

PEGCETACOPLAN MANAGEMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA UNDERGOING MAJOR SURGERIES

EHA Library, M Vara Pampliega, 421419

RITUXIMAB AS TREATMENT FOR ACQUIRED PURE RED CELL APLASIA SECONDARY TO SYSTEMIC LUPUS ERYTHEMATOSUS: A CASE REPORT

EHA Library, Jan Miko Aaron Baybay, 421420

AVATROMBOPAG AS REPLACEMENT THERAPY FOR SEVERE APLASTIC ANEMIA PATIENTS WHO ARE INTOLERANT OR UNRESPONSIVE TO ELTROMBOPAG

EHA Library, HE guangsheng, 421421

MANAGEMENT STRATEGY IN APLASTIC ANEMIA PATIENTS WITH HBV INFECTION FOLLOWING INTENSIVE IMMUNOSUPPRESSIVE THERAPY

EHA Library, Guangsheng He, 421422

INJECTION SITE REACTIONS IN ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WHO RECEIVED SUBCUTANEOUS PEGCETACOPLAN MONOTHERAPY FOR UP TO 3 YEARS

EHA Library, Louise Arnold, 421423

CLINICAL CHARACTERISTICS AND OUTCOMES OF EGYPTIAN CHILDREN WITH FANCONI ANEMIA

EHA Library, Sara Makkeyah, 421424

THE EPIDEMIOLOGY OF APLASTIC ANEMIA IN AFRICA AND THE MIDDLE EAST: A SYSTEMATIC LITERATURE REVIEW

EHA Library, Shahrukh Hashmi, 421425

TREATMENT BURDEN OF PNH PATIENTS IN JAPAN: RESULTS OF THE QUALITATIVE INTERVIEW SURVEY STUDY

EHA Library, Yasutaka Ueda, 421426

IVIG AND DEXAMETHASONE IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH)

EHA Library, Shivani Joshi, 421427

DIAGNOSTIC PATHWAY AND CLINICAL MONITORING OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH): RESULTS FROM A REAL-WORLD STUDY

EHA Library, Markus Radsak, 421428

EXPERIENCE OF PREGNANCY MANAGEMENT IN PATIENTS WITH APLASTIC ANEMIA AT DIFFERENT STAGES OF THE DISEASE

EHA Library, Anastasia Abramova, 421430

EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA: PATIENT-REPORTED OUTCOMES FROM THE PHASE 2 OPEN-LABEL EXTENSION STUDY

EHA Library, Ching Lum, 421431

UNDERSTANDING THE RELATIONSHIP BETWEEN HEMOGLOBIN, FATIGUE AND HEALTH-RELATED QUALITY OF LIFE FOR PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

EHA Library, Jens Panse, 421432

RECOMBINANT HUMAN THROMBOPOIETIN IMPROVES EARLY HEMATOLOGIC RESPONSE IN PATIENTS WITH NEWLY DIAGNOSED TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA

EHA Library, Ziwei Liu, 421433

EXPLORING STRATEGIES TO OPTIMISE OUTCOMES IN HEPATITIS-ASSOCIATED APLASTIC ANAEMIA PATIENTS FOLLOWING HAEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Jia Li, 421434

POST-HEPATITIS APLASTIC ANEMIA,  EXPERIENCE OF SFAX HEAMATOLOGY DEPARTMENT

EHA Library, Nour Siala, 421435

SUCCESSFUL TREATMENT WITH ANTI-COMPLEMENT MOLECULE PEGCETACOPLAN IN LIVER TRANSPLANTATION FOR BUDD-CHIARI SYNDROME IN A PATIENT WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA.

EHA Library, Eduardo José Salido Fiérrez, 421436

PEGCETACOPLAN C3 INHIBITOR IMPROVE RESIDUAL ANEMIA IN PNH PATIENTS UNDER TREATMENT C5 INHIBITORS. EXPERIENCE TERTIARY HOSPITAL

EHA Library, Carmen Gonzalez Gonzalez, 421437

SURVIVAL ANALYSIS OF PATIENTS WITH FANCONI ANEMIA, FROM A SINGLE-CENTER CLINICAL STUDY IN CHINA

EHA Library, yiman gao, 421438

SAFETY, PHARMACOKINETICS, AND PRELIMINARY EFFICACY OF HETROMBOPAG IN PEDIATRIC PATIENTS WITH APLASTIC ANEMIA: A PILOT STUDY

EHA Library, Lixian Chang, 421439

ANALYSIS OF REAL-WORLD DATA TO IDENTIFY PREDICTORS FOR EARLIER DIAGNOSIS OF APLASTIC ANEMIA

EHA Library, Phillip Scheinberg, 421440

THE RELATIONSHIP BETWEEN EARLY DIAGNOSIS/ TREATMENT OF SUSPECTED HLH (HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS ) ON PATIENT SURVIVAL OUTCOMES: A CASE SERIES.

EHA Library, Marina Botros, 421441

TREATMENT LANDSCAPE AND CLINICAL UNMET NEEDS FOR PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN CHINA: RESULTS FROM A REAL-WORLD STUDY

EHA Library, Bing Han, 421442

THE IMPACT OF ONLINE CME/CE ON MULTIDISCIPLINARY TEAM MEMBERS’ ABILITY TO CARE FOR PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Michelle Worst, 421443

RABBIT VERSUS HORSE ATG IN SEVERE APLASTIC ANEMIA- SINGLE CENTER RETROSPECTIVE ANALYSIS

EHA Library, Cemaleddin Ozturk, 421444

LONG-TERM FOLLOW-UP RESULTS FROM CLINICAL STUDY OF HETROMBOPAG COMBINED WITH CYCLOSPORINE A IN THE TREATMENT OF CHILDREN WITH NON-SEVERE APLASTIC ANEMIA

EHA Library, Lixian Chang, 421445

PATIENT-REPORTED DISEASE BURDEN IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN CHINA: RESULTS FROM A REAL-WORLD STUDY

EHA Library, Rong Fu, 421447

THE CLINICAL EFFICACY OF TPO RECEPTOR AGONISTS IN PROMOTING PLATELET RECOVERY AFTER INTENSIVE IMMUNOSUPPRESSION COMBINED WITH UMBILICAL CORD BLOOD TRANSPLANTATION FOR SEVERE APLASTIC ANEMIA.

EHA Library, Zhou fang, 421448

HAEMATOLOGICAL ABNORMALITIES IN PATIENTS WITH ANOREXIA NERVOSA AND OTHER SEVERE EATING DISORDERS IN WHILST IN-PATIENTS AT A SPECIALIST TREATMENT UNIT

EHA Library, Miriam Portela McKean, 421449

NOVEL DESIGNS FOR ENHANCING CAR-T THERAPY AGAINST MULTIPLE MYELOMA TARGETING BCMA

EHA Library, Jorge Illarramendi Esteban, 421450

DYNAMIC CHANGES IN GAMMA DELTA T CELLS AND BONE RESORPTION MARKERS AFTER ZOLEDRONIC ACID IN MULTIPLE MYELOMA: A PROSPECTIVE STUDY

EHA Library, Chao-Hung Wei, 421451

SKY92 MOLECULAR PROFILING IN COMBINATION WITH MRD BY NGS TO IDENTIFY HIGH-RISK MULTIPLE MYELOMA PATIENTS IN IRELAND (MM-PIRE)

EHA Library, Roisin McAvera, 421452

SERUM METABOLIC CHANGES ASSOCIATED WITH THE PROGRESSION FROM MONOCLONAL GAMMOPATHY OF UNCERTAIN SIGNIFICANCE TO SMOLDERING MULTIPLE MYELOMA

EHA Library, Inés Dolz Sales, 421453

MUTATIONAL LANDSCAPE BY NGS IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA. EXPERIENCE OF HEMATOLOGICAL DIAGNOSTIC GROUP OF ALICANTE

EHA Library, Rocio Gonzalez-Martinez, 421454

THE SIDE-EFFECT BURDEN OF TREATMENTS IN MULTIPLE MYELOMA IN A REAL-WORLD POPULATION: EXPLORING THE ONGOING IMPACT OF SIDE-EFFECTS ON THE DAILY LIVES OF PATIENTS

EHA Library, Lauren Kelly, 421455

" BACTERIA INVOLVED IN THE METABOLISM OF SHORT-CHAIN FATTY ACIDS (SCFAS) MAY INFLUENCE THE DEVELOPMENT OF MULTIPLE MYELOMA".

EHA Library, Michał Bator, 421456

NCX1/CA2+ PROMOTES AUTOPHAGY AND DECREASES BORTEZOMIB ACTIVITY IN MULTIPLE MYELOMA THROUGH NON-CANONICAL NFΚB SIGNALING PATHWAY

EHA Library, Tingting Li, 421457

A NOVEL AND PERSONALIZED PRECISION-PDX MODEL FOR ELIMINATION OF MINIMAL RESIDUAL DISEASE( MRD ) FOR PATIENTS WITH MULTIPLE MYELOMA ( MM ) BY MAGNETIC-INDUCED NK CELLS（MAGIC-NK）

EHA Library, Jialu Zhang, 421458

T LYMPHOCYTE SUBGROUPS IN THE BONE MARROW MICRO ENVIRONMENT IN MULTIPLE MYELOMA: TUMOR-DIRECTED T CELLS PLAY A ROLE IN FIGHTING CANCER.

EHA Library, Ali Unal, 421459

PIM2 KINASE REGULATES TIGIT EXPRESSION AND FUNCTION IN NK CELLS FROM MULTIPLE MYELOMA PATIENTS

EHA Library, Zhaoyun Liu, 421460

THE MECHANISM OF STAT3 INHIBITORS INDUCING DNA DAMAGE IN MULTIPLE MYELOMA CELLS AND ENHANCING THE ANTI-TUMOR EFFECTS OF NK CELLS

EHA Library, Zhaoyun Liu, 421461

DISSECTING THE CONTRIBUTION OF CIRCULATING PROTEINS TO MULTIPLE MYELOMA RISK: A MENDELIAN RANDOMIZATION STUDY

EHA Library, Lucy Goudswaard, 421462

NOVEL ANTIGENS LMA AND KMA ARE EXPRESSED ON BONE MARROW PLASMA CELLS FROM PATIENTS WITH AL AMYLOIDOSIS BUT THEY ARE NOT DETECTED ON NORMAL PLASMA CELLS

EHA Library, Aintzane Zabaleta, 421463

OPTIMIZING PRIMARY PATIENT-DERIVED TOTAL MARROW MULTIPLE MYELOMA CELL CULTURE

EHA Library, Ariene Cabantog, 421464

PAEONIFLORIN INHIBITS OSTEOCLAST TRANSFORMATION THROUGH THE ERK1-RANKL PATHWAY

EHA Library, xing cui, 421465

BORTEZOMIB INTERFERES WITH PARKIN-MEDIATED MITOCHONDRIAL AUTOPHAGY LEADING TO NEUROTOXICITY

EHA Library, Xing Cui, 421466

ALOX12 AND THE LIPID LANDSCAPE: IMPLICATIONS FOR THERAPY RESPONSE AND IMMUNOTHERAPY RESISTANCE IN MULTIPLE MYELOMA

EHA Library, Enrico La Spina, 421468

INCREASED LEVELS OF FIBRINOGEN AND TISSUE FACTOR ARE BIOMARKERS OF THROMBOSIS IN PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Tijana Subotički, 421469

UNLOCKING MULTIPLE MYELOMA INSIGHTS: ESTABLISHMENT OF A XENOGRAFT MODEL ON THE CHICK EMBRYO CHORIOALLANTOIC MEMBRANE FOR TUMOUR GROWTH AND DRUG TESTING STUDIES

EHA Library, Izabela Cymer, 421470

THE RISING UNMET NEED FOR MULTIPLE MYELOMA PATIENTS AFTER FIRST-LINE TREATMENT WITH DRD: AN EPIDEMIOLOGICAL ESTIMATE IN ITALY BETWEEN 2024-2028

EHA Library, Mario Boccadoro, 421471

PCDH10 INHIBITS PROLIFERATION, MIGRATION AND ANGIOGENESIS OF MULTIPLE MYELOMA CELLS VIA PI3K/AKT

EHA Library, Chensi Zeng, 421472